Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,564,966
-$14,561,240 QoQ
Shares Held
21,778
-84.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#539
of 1,408 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $170,891,735 across 22 Drug Manufacturers - Specialty & Generic names. ZTS ranks #13 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
128,626 | $69,693,424 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
297,297 | $50,106,435 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
746,855 | $18,380,101 | |
| 4 | ALKS |
Alkermes plc.
|
109,450 | $5,735,180 | |
| 5 | LQDA |
Liquidia Corp
|
46,133 | $3,678,184 | |
| 6 | VTRS |
Viatris Inc
|
230,572 | $3,661,482 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
80,062 | $3,284,943 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
113,125 | $1,958,193 |
All Filings in ZTS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,564,966 | 21,778 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $16,126,206 | 136,420 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $17,923,938 | 142,457 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,068,378 | 34,639 | Shares | Sole | 2025-11-04 | |
| 2024-12-31 | $128,961,862 | 791,517 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $156,606,447 | 801,548 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $155,517,267 | 897,077 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $114,620,820 | 677,388 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $186,043,130 | 942,611 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $159,382,380 | 916,096 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $140,055,463 | 813,283 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $118,090,509 | 709,508 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $90,403,908 | 616,881 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $129,531,609 | 873,502 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $150,520,804 | 875,681 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $170,044,245 | 901,661 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $225,031,042 | 922,145 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $182,819,502 | 941,689 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $122,304,950 | 776,638 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $153,127,219 | 925,240 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $163,120,636 | 986,398 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $166,153,872 | 1,212,448 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $145,548,281 | 1,236,709 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||